No Data
No Data
These 20 Worst-performing Stocks in the S&P 500 Sank 17% or More in March
UBS Spotlights Top 30 Stocks Across All S&P Sectors
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected
TD Cowen Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $100
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $105
150000 US dollars : Ah, me too, I look at it every day, but I have not placed an order.
103517607 150000 US dollars : Me too haha!